Position
Parallel Advisors, LLC in Cullinan Therapeutics, Inc.
Back to the book · All holders of CGEM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $7.32K$10.35 → $14.21
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.9K | $19.6K | — | — | — | 0.0% |
| Q1 2026 | 1.9K | $26.9K | $14.21 | $7.32K | $0 | 0.0% |